A carregar...

Molecular Heterogeneity of Triple Negative Breast Cancer

Triple-negative breast cancers (TNBCs) are known to be an aggressive group of breast cancers with higher rates of relapse stage for stage compared to ER/PR positive and HER2 positive breast cancers despite optimal loco-regional and systemic therapies. To date, not a single targeted therapy has been...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Breast Cancer Rep
Main Authors: Abramson, Vandana G., Mayer, Ingrid A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4235783/
https://ncbi.nlm.nih.gov/pubmed/25419441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-014-0152-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!